What is the recommended treatment for an adult male with acute bacterial prostatitis, chronic bacterial prostatitis, and chronic prostatitis/chronic pelvic pain syndrome?

Treatment of Prostatitis

For acute bacterial prostatitis, treat with fluoroquinolones (ciprofloxacin 500-750 mg orally twice daily) or IV piperacillin-tazobactam for 2-4 weeks; for chronic bacterial prostatitis, use fluoroquinolones for 4-12 weeks; and for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), start with alpha-blockers like tamsulosin rather than antibiotics. 1, 2

Acute Bacterial Prostatitis

Initial Assessment and Hospitalization Criteria

• Hospitalize patients who cannot tolerate oral medications, show signs of systemic toxicity/urosepsis risk, or have suspected prostatic abscess 1
• Perform a gentle digital rectal examination only—never perform vigorous prostatic massage due to bacteremia risk 1, 3
• Obtain midstream urine culture and blood cultures (especially if febrile) before starting antibiotics 1
• Consider transrectal ultrasound if prostatic abscess is suspected 1

Antibiotic Selection for Outpatient Management

First-line oral therapy (mild-to-moderate cases):

• Ciprofloxacin 500-750 mg orally twice daily for 2-4 weeks if local fluoroquinolone resistance is <10% 1, 2
• Avoid fluoroquinolones if resistance >10% or if patient received them in the last 6 months 1
• Avoid amoxicillin/ampicillin empirically due to very high worldwide resistance rates 1
• Avoid trimethoprim-sulfamethoxazole empirically unless organism susceptibility is confirmed 1

For men under 35 years old:

• Add doxycycline 100 mg orally every 12 hours for 7 days to cover Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma species 1
• Alternative: azithromycin 1 g orally as a single dose for Mycoplasma coverage 1

Antibiotic Selection for Inpatient Management

First-line IV therapy (severe cases):

• Ciprofloxacin 400 mg IV twice daily, transitioning to oral once clinically improved 1
• Piperacillin-tazobactam 4.5 g IV every 6-8 hours 4, 2
• Ceftriaxone 1-2 g IV daily 1, 2

For healthcare-associated infections with suspected enterococci:

• Use ampicillin, piperacillin-tazobactam, or vancomycin based on susceptibility for Enterococcus faecalis 1
• Consider carbapenems or novel broad-spectrum agents only when early culture results confirm multidrug-resistant organisms 1

Treatment Duration and Follow-Up

• Assess clinical response after 48-72 hours of treatment 1
• Complete a total of 2-4 weeks of antibiotic therapy 5, 1, 2
• Stopping antibiotics prematurely can lead to chronic bacterial prostatitis—complete the full course 1

---

Chronic Bacterial Prostatitis

Diagnostic Confirmation

• Perform the Meares-Stamey 4-glass test (or simplified 2-specimen variant) to confirm diagnosis 1, 3
• A positive result requires a 10-fold higher bacterial count in expressed prostatic secretions compared to midstream urine 1, 3
• Prostatic massage is safe in chronic bacterial prostatitis (unlike acute) 6

Antibiotic Selection

First-line therapy:

• Levofloxacin or ciprofloxacin for a minimum of 4 weeks 2, 7
• Fluoroquinolones are preferred due to superior prostatic tissue penetration (penetration ratios up to 4:1) 6, 8, 7
• Treatment duration of 4-12 weeks is required to prevent relapse 1

Key considerations:

• Up to 74% of chronic bacterial prostatitis cases are caused by gram-negative organisms, particularly E. coli 1, 3
• If no improvement after 2-4 weeks, stop and reconsider treatment; if improvement occurs, continue for at least another 2-4 weeks 6
• Do not treat for 6-8 weeks without appraising effectiveness 6

---

Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

Diagnostic Approach

• CP/CPPS is diagnosed when pelvic pain or discomfort persists for at least 3 months with urinary symptoms, and evaluation excludes infection, cancer, obstruction, or retention 2
• Rule out bacterial infection with the Meares-Stamey test and test for atypical pathogens (Chlamydia, Mycoplasma) 1
• CP/CPPS is not frequently caused by culturable infectious agents—management focuses on symptom relief, not antimicrobials 1

First-Line Treatment

Alpha-blockers (for patients with urinary symptoms):

• Tamsulosin or alfuzosin as first-line therapy 2, 9
• Alpha-blockers reduce NIH-CPSI scores by 10.8 to 4.8 points compared to placebo 2
• Treatment responses are greater with longer durations (6-24 weeks) in alpha-blocker-naïve patients 7

Additional Treatment Options

If alpha-blockers are insufficient:

• Anti-inflammatory drugs (ibuprofen): reduce NIH-CPSI scores by 2.5 to 1.7 points 2
• Pregabalin: reduces NIH-CPSI scores by 2.4 points 2
• Pollen extract: reduces NIH-CPSI scores by 2.49 points 2

Multimodal therapy:

• A stepwise approach involving antibiotics followed by bioflavonoids and then alpha-blockers can reduce symptoms for up to 1 year (mean NIH-CPSI reduction of 9.5 points) 7
• Combination therapy (alpha-blocker + anti-inflammatory + muscle relaxant) does not offer significant advantages over monotherapy 7
• Consider electromagnetic or electroacupuncture therapy for patients with multiple unsuccessful treatment regimens 7

---

Prostatic Abscess (Complication of Acute Bacterial Prostatitis)

Immediate Management

• Percutaneous drainage under transrectal ultrasound guidance is first-line due to lower complication rates and shorter hospital stays 4
• Antibiotics alone are insufficient—drainage is mandatory for source control 4
• Transrectal needle aspiration or small-bore pigtail catheter placement is superior to conservative management 4

Antibiotic Therapy

• Piperacillin-tazobactam 4.5 g IV every 6-8 hours as first-line 4
• For multidrug-resistant E. coli, consider carbapenems (ertapenem 1 g daily, meropenem 1 g every 8 hours, or imipenem-cilastatin 1 g every 6-8 hours) 4
• Culture abscess fluid at the time of drainage to confirm pathogen and guide therapy 4

Critical Pitfalls

• Never attempt prostatic massage in suspected abscess—this risks bacteremia and sepsis 4
• Maintain high clinical suspicion in older, debilitated, diabetic, or immunosuppressed patients 4

---

Common Pitfalls to Avoid

• Do not use cefpodoxime for prostatitis—it has poor prostatic tissue penetration despite efficacy in pyelonephritis 1
• Avoid fluoroquinolones if local resistance exceeds 10% or if the patient received them in the last 6 months 1
• Do not give antibiotics for CP/CPPS without evidence of bacterial infection—this condition requires symptom-directed therapy, not antimicrobials 1, 2
• Ensure all sexual partners within the preceding 60 days are evaluated and treated when sexually transmitted pathogens are identified 1
• Patients should abstain from sexual activity until 7 days after initiating therapy and after symptoms resolve 1